首页 正文

Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)

{{output}}
Myeloperoxidase (MPO), a key enzyme involved in neutrophil extracellular trap formation and other inflammatory processes, has emerged as an attractive therapeutic target for cardiovascular, central nervous system, respiratory, and autoimmune diseases. To date,... ...